DailyStocks Stock Article Search

https://seekingalpha.com/article/4675920-multifactor-solution-top-heavy-market?source=feed_tag_etf_portfolio_strategy Mar 05, 2024 - The growing dominance of a few richly valued companies has elevated S&P 500 valuations - lowering future return forecasts - and reduced the diversification benefits of index-based investing. 0

https://seekingalpha.com/article/4675879-3-top-dividend-stocks-for-march-2024?source=feed Mar 05, 2024 - Bitcoin and AI stocks are soaring, while dividend stocks are struggling due to elevated cost of capital and sticky inflation. Read about 3 top picks for 2024. 0

https://www.zacks.com/stock/news/2235633/nektar-therapeutics-nktr-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2235633 Mar 04, 2024 - Nektar (NKTR) delivered earnings and revenue surprises of -10% and 39.75%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2235631/ekso-bionics-ekso-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2235631 Mar 04, 2024 - Ekso Bionics (EKSO) delivered earnings and revenue surprises of -100% and 0.98%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2235625/thredup-tdup-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2235625 Mar 04, 2024 - ThredUp (TDUP) delivered earnings and revenue surprises of -7.69% and 1.36%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2235626/akoya-biosciences-akya-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2235626 Mar 04, 2024 - Akoya (AKYA) delivered earnings and revenue surprises of 18.52% and 1.41%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/stock/news/2235627/cara-therapeutics-cara-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2235627 Mar 04, 2024 - Cara (CARA) delivered earnings and revenue surprises of -3.51% and 28.60%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock? 0

https://www.zacks.com/commentary/2235614/3-top-ranked-stocks-to-buy-for-big-growth?cid=CS-ZC-FT-investment_ideas-2235614 Mar 04, 2024 - Growth-focused investors have been rewarded handsomely over the last year, enjoying considerable gains. And for those wanting to join the party, these three stocks could be a place to start. 0

https://www.zacks.com/stock/news/2235615/top-stock-picks-for-week-of-march-4-2024?cid=CS-ZC-FT-video_blog-2235615 Mar 04, 2024 - An Underestimated AI Leader and a Regional Airline Delivering an Average Triple Digit Earnings Surprise. 0

https://www.zacks.com/commentary/2235274/top-research-reports-for-broadcom-totalenergies-lam-research?cid=CS-ZC-FT-research_daily-2235274 Mar 04, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), TotalEnergies SE (TTE) and Lam Research Corp. (LRCX). 0